A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model

Cancer Letters

Volumn 308, Issue 1, 2011, Pages 33-42

  Tepaamorndech, Surapun ^a   Huang, Liping ^a,b   Kirschke, Catherine P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Prostate cancer; SV40 T antigen; TRAMP; Zinc transporters; Znt7

Indexed keywords

UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 7;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; TRANSGENICS; ZNT7 GENE;

ADENOCARCINOMA; ANIMALS; CATION TRANSPORT PROTEINS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25;

MUS;

EID: 80955177114     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.04.011     Document Type: Article

References (42)

1. Aumüller G. Prostate Gland and Seminal Vesicles 1979, Springer-Verlag, New York.
2. Sorensen M.B., Stoltenberg M., Juhl S., Danscher G., Ernst E. Ultrastructural localization of zinc ions in the rat prostate: an autometallographic study. Prostate 1998, 31:125-130.
3. Gyorkey F., Min K.W., Huff J.A., Gyorkey P. Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Cancer Res. 1967, 27:1348-1353.
4. Vartsky D., Shilstein S., Bercovich Huszar Breskin A., Chechik R., Korotinsky S., Malnick S.D., Moriel E. Prostatic zinc and prostate specific antigen: an experimental evaluation of their combined diagnostic value. J. Urol. 2003, 170:2258-2262.
5. Zaichick V.Y., Sviridova T.V., Zaichick S.V. Zinc in the human prostate gland: normal, hyperplastic, cancerous. Int. Urol. Nephrol. 1997, 29:565-574.
6. Ghosh S.K., Kim P., Zhang X.A., Yun S.H., Moore A., Lippard S.J., Medarova Z. A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing. Cancer Res. 2010, 70:6119-6127.
7. Huang L., Kirschke C.P., Zhang Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 2006, 6:10-22.
8. Huang L., Yu Y.Y., Kirschke C.P., Gertz E.R., Lloyd K.K. Znt7 (Slc30a7)-deficient mice display reduced body zinc status and body fat accumulation. J. Biol. Chem. 2007, 282:37053-37063.
9. Greenberg N.M., DeMayo F., Finegold M.J., Medina D., Tilley W.D., Aspinall J.O., Cunha G.R., Donjacour A.A., Matusik R.J., Rosen J.M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 1995, 92:3439-3443.
10. Gingrich J.R., Barrios R.J., Foster B.A., Greenberg N.M. Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis. 1999, 2:70-75.
11. Gingrich J.R., Barrios B.J., Morton R.A., Boyce B.F., DeMayo F.J., Finegold M.J., Angelopoulou R., Rosen J.M., Greenberg N.M. Metastatic prostate cancer in a transgenic mouse. Cancer Res. 1996, 56:4096-4102.
12. Yan Y., Sheppard P.C., Kasper S., Lin L., Hoare S., Kapoor A., Dodd J.G., Duckworth M.L., Matusik R.J. Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice. Prostate 1997, 32:129-139.
13. Matusik R.J., Kreis C., McNicol P., Sweetland R., Mullin C., Fleming W.H., Dodd J.G. Regulation of prostatic genes: role of androgens and zinc in gene expression. Biochem. Cell Biol. 1986, 64:601-607.
14. Kirschke C.P., Huang L. ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J. Biol. Chem. 2003, 278:4096-4102.
15. Seve M., Chimienti F., Devergnas S., Favier A. In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression. BMC Genomics 2004, 5:32-40.
16. Palmiter R. Protection against zinc toxicity by metallothionein and zinc transporter 1. Proc. Natl. Acad. Sci. USA 2004, 101:4918-4923.
17. Overbeck S., Uciechowski P., Ackland M.L., Ford D., Rink L. Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J. Leukocyte Biol. 2008, 83:368-380.
18. Palmiter R.D., Findley S.D. Cloning and characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 1995, 14:639-649.
19. Kirschke C.P., Huang L. Expression of ZNT (SLC30) family members in the epithelium of the mouse prostate during sexual maturation. J. Mol. Histol. 2008, 39:359-370.
20. Andree K., Kim J., Kirschke C.P., Gregg J.P., Paik H., Joung H., Woodhouse L., King J.C., Huang L. Investigation of lymphocyte gene expression for use as biomarkers for zinc status in humans. J. Nutr. 2004, 134:1716-1723.
21. Shappell S.B., Thomas G.V., Roberts R.L., Herbert R., Ittmann M.M., Rubin M.A., Humphrey P.A., Sundberg J.P., Rozengurt N., Barrios R., Ward J.M., Cardiff R.D. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee. Cancer Res. 2004, 64:2270-2305.
22. Yu Y.Y., Kirschke C.P., Huang L. Immunohistochemical analysis of ZnT1, 4, 5, 6, and 7 in the mouse gastrointestinal tract. J. Histochem. Cytochem. 2007, 55:223-234.
23. Masumori N., Thomas T.Z., Chaurand P., Case T., Paul M., Kasper S., Caprioli R.M., Tsukamoto T., Shappell S.B., Matusik R.J. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res. 2001, 61:2239-2249.
24. Wang L., Bonorden M.J.L., Li G.X., Lee H.J., Hu H., Zhang Y., Liao J.D., Cleary M.P., Lü J. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev. Res. (Phila) 2009, 2:484-495.
25. Franklin R., Ma J., Zou J., Guan Z., Kukoyi B.I., Feng P., Costello L.C. Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J. Inorg. Biochem. 2003, 96:435-442.
26. Costello L.C., Feng P., Milon B., Tan M., Franklin R.B. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis. 2004, 7:111-117.
27. Kasper S., Matusik R.J. Rat probasin: structure and function of an outlier lipocalin. Biochim. Biophys. Acta 2000, 1482:249-258.
28. Greenberg N.M., DeMayo F.J., Sheppard P.C., Barrios R., Lebovitz R., Finegold M., Angelopoulou R., Dodd J.G., Duckworth M.L., Rosen J.M., Matusik R.J. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol. 1994, 8:230-239.
29. Johnson M.A., Hernandez I., Wei Y., Greenberg N. Isolation and characterization of mouse probasin: an androgen-regulated protein specifically expressed in the differentiated prostate. Prostate 2000, 43:255-262.
30. Brinkmanna A.O., Bloka L.J., de Ruitera P.E., Doesburgb P., Steketeeb K., Berrevoetsa C.A., Trapmanb J. Mechanisms of androgen receptor activation and function. J. Steroid Biochem. Mol. Biol. 1999, 69:307-313.
31. Feng P., Liang J.Y., Li T.L., Guan Z.X., Zou J., Franklin R., Costello L.C. Zinc induces mitochondria apoptogenesis in prostate cells. Mol. Urol. 2000, 4:31-36.
32. Feng P., Li T.L., Guan Z.X., Franklin R.B., Costello L.C. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 2002, 52:311-318.
33. Feng P., Li T., Guan Z., Franklin R.B., Costello L.C. The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. Mol. Cancer 2008, 7:25.
34. Liang J.Y., Liu Y.Y., Zou J., Franklin R.B., Costello L.C., Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999, 40:200-207.
35. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell Biol. 2002, 9:459-470.
36. Perry D.K., Smyth M.J., Stennicke H.R., Salvesen G.S., Duriez P., Poireier G.G., Hannun Y.A. Zinc is potent inhibitor of the apoptotic protease Caspase-3. J. Biol. Chem. 1997, 272:18530-18533.
37. Gupta A., Sharma V.K., Vohra H., Ganguly N.K. Inhibition of apoptosis by inonmycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients. Clin. Exp. Immunol. 1999, 117:56-62.
38. Wang X., Wu Y., Zhou B. Dietary zinc absorption is mediated by ZnT1 in Drosophila melanogaster. FASEB J. 1995, 23:2650-2661.
39. Abnet C.C., Lai B., Qiao Y.-L., Vogt S., Luo X.-M., Taylor P.R., Dong Z.-W., Mark S.D., Dawsey S.M. Zinc concentration in esophageal biopsy specimens measured by X-ray fluorescence and esophageal cancer risk. J. Natl. Cancer Inst. 2005, 97:301-306.
40. Fong L.Y., Magee P.N. Dietary zinc deficiency enhances esophageal cell proliferation and N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor incidence in C57BL/6 mouse. Cancer Lett. 1999, 143:63-69.
41. Fong L.Y., Li J.X., Farber J.L., Magee P.N. Cell proliferation and esophageal carcinogenesis in the zinc-deficient rat. Carcinogenesis 1996, 17:1841-1848.
42. Fong L.Y., Farber J.L., Magee P.N. Zinc replenishment reduces esophageal cell proliferation and N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor incidence in zinc-deficient rats. Carcinogenesis 1998, 19:1591-1596.